Medipharm Labs Corp (LABS) — Capital Reinvestment Ratio
Latest as of December 2025:
0.23x
Medipharm Labs Corp (LABS) has a Capital Reinvestment Ratio of 0.23x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$435.00K) in capital expenditures (CA$100.00K). See Medipharm Labs Corp (LABS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.23x
Capex / Operating Cash Flow
Operating Cash Flow
CA$435.00K
CAD
Capital Expenditures
CA$100.00K
CAD
Data as of
Dec 2025
Most recent filing
Medipharm Labs Corp Capital Reinvestment Ratio (2017–2017)
This chart tracks Medipharm Labs Corp's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Medipharm Labs Corp (2017–2017)
Year-by-year Capital Reinvestment Ratio for Medipharm Labs Corp from 2017 to 2017. For live market cap and broader valuation context, see market cap of Medipharm Labs Corp.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 12.92x | CA$166.00K | CA$2.14 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow